Compare up to 4 stocks side by side, across all 7 of StockIQ's scoring categories.
| Category | PPBT Purple Biotech Ltd. | AAPG Ascentage Pharma Group International - American Depository |
|---|---|---|
| Price | $1.52 +0.0% | $16.31 +9.5% |
| StockIQ Score | 30F Weak Risk: High | 42D Weak Risk: Medium |
| Technical | 18F | 36F |
| Fundamental | — | 35F |
| Growth | — | 50C- |
| Fair Value | — | 38F |
| News | 56C | 50C- |
| Quality | — | 50C- |
| Risk | 34F | 48D+ |
Scores are based on real financial data only and do not constitute investment advice. How the score is calculated
Purple Biotech (PPBT) has a much lower investor score (30) compared to Ascentage Pharma (AAPG, 42), showing weaker investor sentiment. AAPG also outperforms in technical (36 vs. 18), fundamental (35 vs. unavailable), and growth (50 vs. unavailable) scores, indicating stronger overall performance metrics. Both share the same "WEAK" rating, but AAPG shows clear advantages in measurable strengths.
